Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors

Stem Cells

Volumn 15, Issue 1, 1997, Pages 33-42

  Rasko, John E J ^a   O'Flaherty, Elizabeth ^a   Begley, C Glenn ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

c mpl; Meg CFC; MGDF; Progenitor; Proliferation; SCF; Survival; Thrombopoietin

Indexed keywords

MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; STEM CELL FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENIC ASSAY; COLONY FORMING UNIT; GRANULOCYTE; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; STEM CELL; THROMBOCYTE AGGREGATION;

EID: 0031033837     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150033     Document Type: Article

References (53)

1. Morstyn G, Nicola NA, Metcalf D. Separate actions of different colony stimulating factors from human placental conditioned medium on human hemopoietic progenitor cell survival and proliferation. J Cell Physiol 1981;109:133-142.
2. Begley CG, Lopez AF, Nicola NA et al. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 1986;68:162-166.
3. Williams GT, Smith CA, Spooncer E et al. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990;343:76-79.
4. Fairbairn LJ, Cowling GJ, Reipert BM et al. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993;74:823-832.
5. Vigon I, Mornon JP, Cocault L et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992;89:5640-5644.
6. Zeigler FC, de Sauvage F, Widmer HR et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994;84:4045-4052.
7. Berardi AC, Wang AL, Levine JD et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-108.
8. Kobayashi M, Laver JH, Kato T et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with Steel factor and/or interleukin 3. Blood 1996;88:429-436.
9. Debili N, Issaad C, Masse JM et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992;80:3022-3035.
10. Methia N, Louache F, Vainchenker W et al. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoeisis. Blood 1993;82:1395-1401.
11. Nichol JL, Hornkohl AC, Choi ES et al. Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid culture. STEM CELLS 1994;12:494-505.
12. Debili N, Wendling F, Cosman D et al. The mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391-401.
13. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
14. de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
15. Lok S, Kaushansky K, Holly RD et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
16. Wendling F, Maraskovsky E, Debili N et al. c-mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571-574.
17. Sohma Y, Akahori H, Seki N et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994;353:57-61.
18. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
19. Kobayashi M, Laver JH, Kato T et al. Recombinant human thrombopoietin (mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995;86:2494-2499.
20. Kaushansky K, Broudy VC, Grossmann A et al. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 1995;96:1683-1687.
21. Choi ES, Hokom M, Bartley T et al. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. STEM CELLS 1995;13:317-322.
22. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-1726.
23. Chen J, Herceg-Harjacek L, Groopman JE et al. Regulation of platelet activation in vitro by the c-mpl ligand, thrombopoietin. Blood 1995;86:4054-4062.
24. Toombs CF, Young CH, Glaspy JA et al. Megakaryocyte growth and development factor (MGDF) moderately enhances in-vitro platelet aggregation. Thromb Res 1995;80:23-33.
25. DeLuca E, Sheridan WP, Watson D et al. Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992;66:893-899.
26. Begley CG. Human progenitor cell assays. In: Morstyn G, Sheridan WP, eds. Cell Therapy. Cambridge: Cambridge University Press, 1996:59-74.
27. Rasko JEJ, Metcalf D, Rossner MT et al. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 1995;9:2058-2066.
28. + purified cells from human cord blood and bone marrow. STEM CELLS 1995;13:281-288.
29. Macedo A, Orfao A, Ciudad J et al. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukemia 1995;9:1896-1901.
30. Zauli G, Valvassori L, Capitani S. Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. Blood 1993;81:385-390.
31. Miyazaki H, Inoue H, Yanagida M et al. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Exp Hematol 1992;20:855-861.
32. Metcalf D. Clonal Culture of Hemopoietic Cells: Techniques and Applications. Amsterdam, The Netherlands: Elsevier, 1984.
33. Zhang JL, Stenberg PE, Baker G et al. Immunocytochemical identification of murine and human megakaryocyte colonies in soft-agar cultures. Histochemical J 1994;26:170-178.
34. Mazur EM, Hoffman R, Chasis J et al. Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum. Blood 1981;57:277-286.
35. Teramura M, Katahira J, Hoshino S et al. Effect of recombinant hemopoietic growth factors on human megakaryocyte colony formation in serum-free cultures. Exp Hematol 1989;17:1011-1016.
36. Jiang S, Levine JD, Fu Y et al. Cytokine production by primary bone marrow megakaryocytes. Blood 1994;84:4151-4156.
37. Navarro S, Debili N, Le Couedic JP et al. Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood 1991;77:461-471.
38. Kaushansky K, Broudy VC, Lin N et al. Thrombopoietin, the mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995;92:3234-3238.
39. + marrow cells. Blood 1995;86:2161-2167.
40. Pech N, Hermine O, Goldwasser E. Further study of internal autocrine regulation of multipotent hematopoietic cells. Blood 1993;82:1502-1506.
41. Hermine O, Beru N, Pech N et al. An autocrine role for erythropoietin in mouse hematopoietic cell differentiation. Blood 1991;78:2253-2260.
42. Metcalf D, MacDonald HR. Heterogeneity of in vitro colony-and cluster-forming cells in the mouse marrow: segregation by velocity sedimentation. J Cell Physiol 1975;85:643-654.
43. Roberts AW, Deluca E, Begley CG et al. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. STEM CELLS 1995;13:512-516.
44. Debili N, Wendling F, Katz A et al. The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995;86:2516-2525.
45. Berthier R, Valiron O, Schweitzer A et al. Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: role of TGFβ. STEM CELLS 1993;11:120-129.
46. Matsuguchi T, Salgia R, Hallek M et al. She phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210(BCR/ABL). J Biol Chem 1994;269:5016-5021.
47. Blume-Jensen P, Ronnstrand L, Gout I et al. Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C. J Biol Chem 1994;269:21793-21802.
48. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
49. Pallard C, Gouilleux F, Benit L et al. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 1995;14:2847-2856.
50. Kanaji T, Okamura T, Nagafuji K et al. Megakaryocytes produce the receptor for granulocyte colony-stimulating factor. Blood 1995;85:3359-3360.
51. Shimoda K, Okamura S, Harada N et al. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 1993;91:1310-1313.
52. Basser RL, Rasko JEJ, Clarke K et al. Thrombopoietin effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). Lancet 1996;348:1279-1281.
53. O'Malley CJ, Rasko JEJ, Basser RL et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996;88:3288-3298.